Skip to main content
TipRanks
Go Ultimate75% OFF

Heron Therapeutics (AXD2) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

AXD2 Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Heron Therapeutics in the past 3 months

AXD2 Stock 12 Month Forecast

There Are No Analyst Ratings for AXD2 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:AXD2
Price TargetArticle
H.C. Wainwright―hold―Reiterated11/13/26
Needham―hold―Reiterated08/10/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Heron Therapeutics

3 Months
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate1/2 ratings generated profit
50%
Average Return
+0.45%

Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.45% per trade.

1 Year
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate1/2 ratings generated profit
50%
Average Return
+0.45%

Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.45% per trade.

2 Years
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate1/2 ratings generated profit
50%
Average Return
+0.45%

Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.45% per trade.

AXD2 Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for AXD2
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy42000
Buy00000
Hold14331
Sell00000
Strong Sell00000
total56331

In the current month, AXD2 has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AXD2 average Analyst price target in the past 3 months is ―.

AXD2 Financial Forecast

CHF-2CHF-1.5CHF-1CHF-0.5CHF0Q1 2026Q3 2026Q4 2026
HighCHF-0.02
ConsensusCHF-0.03
LowCHF-0.03

AXD2 Earnings Forecast

Next quarter’s earnings estimate for AXD2 is -CHF 0.03 with a range of -CHF 0.03 to -CHF 0.02. The previous quarter’s EPS was -CHF 0.03. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

CHF26.4MCHF28.3MCHF30.2MCHF32.2MCHF34.1MQ1 2026Q3 2026Q4 2026
HighCHF30.6M
ConsensusCHF28.5M
LowCHF26.4M

AXD2 Sales Forecast

Next quarter’s sales forecast for AXD2 is CHF 28.53M with a range of CHF 26.43M to CHF 30.63M. The previous quarter’s sales results were CHF 29.58M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

AXD2 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Heron Therapeutics a Buy, Sell or Hold?
Heron Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about Heron Therapeutics?
Heron Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Heron Therapeutics?
To buy shares of CH:AXD2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.